Skip to main content

Court Blocks California's Glyphosate Warning Rule

Court Blocks California's Glyphosate Warning Rule

Introduction

A divided federal appeals court has ruled that California cannot mandate businesses to warn consumers about the potential dangers of glyphosate, an ingredient in the Roundup weedkiller linked to cancer.

The 9th U.S. Circuit Court of Appeals in San Francisco, upholding a permanent injunction, declared it unconstitutional to compel Bayer's Monsanto unit, the maker of Roundup, and other agricultural businesses to provide the proposed carcinogen warnings under California's Proposition 65.

In a 2-1 majority decision, the Circuit Judge stated that turning producers into a "billboard" for California's "at best, disputed" message on the alleged unsafety of glyphosate violated their First Amendment commercial speech rights, despite the state's significant interest in its citizens' health.

The judge argued that forcing sellers to warn consumers of a potential 'risk' not confirmed by any regulatory body or not 'known' to more than a small scientific subset does not directly serve the state's interest.

Bayer praised the decision as a "strong blow against compelled warnings for Roundup that are not supported by science" and deemed it crucial for the company's ongoing personal injury litigation.

Initially linking glyphosate to cancer, California's original warnings were revised last year, citing the International Agency for Research on Cancer's findings that glyphosate was "probably carcinogenic" to humans.

Rejecting all warnings, the judge noted that they required Bayer and other objectors to convey a "controversial, fiercely contested message that they fundamentally disagree with."

The ruling upheld a June 2020 injunction by a U.S. District Judge in California. The office of the California Attorney General expressed disappointment, declining to disclose plans for another appeal. Lawyers for 13 agriculture and business trade groups opposing the warnings did not immediately respond.

Bayer has faced extensive Roundup litigation, with three trial losses last month, since acquiring Monsanto for $63 billion in 2018. Although settling most Roundup claims for $10.9 billion in 2020, the company still faced about 45,000 claims by early this year.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Court Approves $700M Opioid Settlement for Acute Hospitals

Categories: Opioids

A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.

The settlement consolidates four separate agreements involving major drug…

Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B

Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.

The breakdown of the foam in these machines may release harmful chemicals, raising serious…

Texas Trial to Decide J&J’s $10B Talcum Powder Settlement

Categories: Talcum

A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…

🎁 March VIP Medical Record Review Offer – Get 300 Pages Free!         
Includes a Free Life Care Plan Report + 10% Off Future Reviews!

Only 15 Firms Accepted.